CD8A and neoplasm: Moreover, in tumor-infiltrating miR-155-deficient CD8+ T cells, antibodies against immune checkpoint proteins restored the expression of several derepressed miR-155 targets, suggesting that miR-155 and ICB regulate overlapping pathways to promote antitumor immunity.